文献速递主动脉疾病外周动脉疾病

髂内动脉瘤的血管腔内治疗

Endovascular treatment of hypogastric artery aneurysms.
PubMed 文献 · J Vasc Surg · 2019-05-27

该单中心回顾性研究分析了46例连续接受血管腔内治疗的髂内动脉瘤(IIAA)患者,共55个IIAA。采用髂动脉分支装置(IBD)植入、髂内动脉(IIA)开口覆盖伴或不伴弹簧圈栓塞及其他腔内技术。IBD植入的初级辅助技术成功率为93.1%,中期辅助通畅率为93.1%;30天总死亡率为4.3%,择期患者为0%。

要点

  • IBD植入治疗IIAA技术成功率高、围手术期并发症少。
  • 保留盆腔血流的IBD植入中期再干预率高于IIA开口覆盖。
  • 臀肌跛行发生于15.2%的IIA或臀上动脉闭塞患者。

核心结论

  • IBD装置植入治疗髂内动脉瘤技术结果良好,初级通畅率高且围手术期并发症率低。
  • 成功排除动脉瘤并保留盆腔血流与中期随访再干预率较高相关,在复杂主髂动脉瘤腔内修复中仍应考虑。

研究设计与样本

  • 单中心主髂动脉数据库的回顾性分析,纳入2009年9月至2016年5月连续46例血管腔内治疗的IIAA患者,共55个IIAA。

主要发现

  • 39例(84.8%)合并主髂动脉瘤,7例(15.2%)为孤立性IIAA。
  • IBD植入29例,IIA开口覆盖伴或不伴弹簧圈栓塞23例,其他腔内技术3例。
  • IBD植入的初级辅助技术成功率为93.1%,开口覆盖及其他技术为100%。
  • 总体30天死亡率为4.3%(2例),择期治疗患者为0%。
  • IBD植入后辅助中期通畅率为93.1%;臀肌跛行发生于7例(15.2%)IIA或臀上动脉闭塞患者。

临床怎么用

  • 对于适合的IIAA患者,可考虑IBD植入以保留盆腔血流并可靠排除动脉瘤。
  • 需权衡IBD植入后中期再干预率较高的风险,尤其在复杂主髂动脉瘤腔内修复中。

局限性

  • 回顾性单中心研究,样本量有限(46例患者,55个IIAA)。
  • 中期随访再干预率基于小样本事件数(IBD组4例,开口覆盖组1例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Internal iliac artery aneurysm (IIAA) is a rare entity. Its treatment can be technically challenging. The aim of this study was to evaluate the treatment possibilities in an era of advanced endovascular techniques and their potential to preserve iliac blood flow while reliably excluding the aneurysm. METHODS: A retrospective analysis of 46 consecutive patients with endovascularly treated IIAA was performed. Data were collected from a single-institution aortoiliac database. The following end points were recorded: technique of aneurysm exclusion, technical success rates, perioperative morbidity and mortality, primary patency, and midterm follow-up. RESULTS: Between September 2009 and May 2016, a total of 46 patients with 55 IIAAs were identified. The majority of patients (n = 39 [84.8%]) had aortoiliac aneurysms and seven had isolated IIAAs (15.2%). The following surgical techniques were used: implantation of iliac branch devices (IBDs; n = 29), occlusion of the internal iliac artery (IIA) by ostium coverage with or without prior coil embolization (n = 23), and other endovascular techniques (n = 3). Primary assisted technical success was achieved in 93.1% of IBD implantations and in 100% of occlusions by ostium coverage and other techniques. Overall 30-day mortality was 4.3% (n = 2) and 0% in electively treated patients. Assisted midterm patency after IBD implantation was 93.1%. Gluteal claudication occurred in seven patients (15.2%) who had undergone intentional or accidental occlusion of the IIA or the superior gluteal artery. Reintervention rates within the midterm follow-up were 13.8% (n = 4) after IBD implantation and 4.3% (n = 1) after coverage of the IIA ostium. No ruptures were observed during follow-up, and no complications occurred during reinterventions. CONCLUSIONS: Implantation of IBD devices for the treatment of hypogastric artery aneurysms shows good technical results with a high primary patency and a low rate of perioperative complications. Although successful aneurysm exclusion while preserving pelvic blood flow is associated with a higher rate of reinterventions during midterm follow-up, it should be taken into consideration, especially in complex endovascular aortoiliac aneurysm repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kliewer M, Plimon M, Taher F, et al. Endovascular treatment of hypogastric artery aneurysms. J Vasc Surg. 2019. PMID: 31147136. doi:10.1016/j.jvs.2018.12.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。